ViewRay Announces Conference Call for Second Quarter 2022 Financial Results to be Held After Market on August 2, 2022
ViewRay, Inc. (Nasdaq: VRAY) will release its first quarter 2022 financial results on August 2, 2022, followed by a conference call at 4:30 p.m. ET.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Summary
ViewRay, Inc. (Nasdaq: VRAY) will release its first quarter 2022 financial results on August 2, 2022, followed by a conference call at 4:30 p.m. ET. Investors can join via dial-in numbers or listen to a live webcast on the company's investor relations page. A replay will be available online for 14 days, and telephonic replays will be accessible until August 16, 2022. ViewRay specializes in MR-guided radiation therapy systems, particularly the MRIdian system, designed to enhance treatment in radiation oncology.
Positive
- Scheduled financial results call for Q1 2022 signifies transparency and investor engagement
- MRIdian system tailored for addressing specific challenges in radiation oncology demonstrates product innovation
Negative
- None.
Details
News Market Reaction – VRAY
The recorded move for VRAY in the trading session of this news was +7.75%.
Data tracked by StockTitan Argus. Session date unavailable.
AI-generated analysis. How Rhea-AI works. Not financial advice.
CLEVELAND, July 19, 2022 /PRNewswire/ -- ViewRay, Inc. (Nasdaq: VRAY) announced today details relating to the release of its first quarter 2022 financial results.
ViewRay will hold a conference call to discuss results on Tuesday, August 2, 2022 at 4:30 p.m. ET. The dial-in numbers are (646) 307-1952 for domestic callers and (888) 672-2415 for international callers. The confirmation number is 7750966. A live webcast of the conference call will be available on the investor relations page of ViewRay's corporate website at http://investors.viewray.com/events-and-presentations/upcoming-events.
After the live webcast, a replay will remain available online on the investor relations page of ViewRay's website, under "Financial Events and Webinars", for 14 days following the call. In addition, a telephonic replay of the call will be available until August 16, 2022. The replay dial-in numbers are (800) 770-2030 for domestic callers and (609) 800-9909 for international callers. Please use the conference ID number 7750966.
ViewRay, Inc. (Nasdaq: VRAY), designs, manufactures, and markets the MRIdian® MR-Guided Radiation Therapy System. MRIdian is built upon a proprietary high-definition MR imaging system designed from the ground up to address the unique challenges and clinical workflow for advanced radiation oncology. Unlike MR systems used in diagnostic radiology, MRIdian's high-definition MR was purpose-built to address specific challenges, including beam distortion, skin toxicity, and other concerns that potentially may arise when high magnetic fields interact with radiation beams. ViewRay and MRIdian are registered trademarks of ViewRay, Inc.
View original content:https://www.prnewswire.com/news-releases/viewray-announces-conference-call-for-second-quarter-2022-financial-results-to-be-held-after-market-on-august-2-2022-301588810.html
SOURCE ViewRay, Inc.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.